90 related articles for article (PubMed ID: 16938291)
1. GLC756 decreases TNF-alpha via an alpha2 and beta2 adrenoceptor related mechanism.
Laengle UW; Trendelenburg AU; Markstein R; Nogues V; Provencher-Bollinger A; Roman D
Exp Eye Res; 2006 Nov; 83(5):1246-51. PubMed ID: 16938291
[TBL] [Abstract][Full Text] [Related]
2. Effects of anti-glaucoma drugs timolol and GLC756, a novel mixed dopamine D2 receptor agonist and D1 receptor antagonist, on endotoxin-induced-uveitis and -arthritis in rats.
Laengle UW; Court M; Markstein R; Germann PG; Nogues V; Roman D
Exp Toxicol Pathol; 2005 Nov; 57(2):127-34. PubMed ID: 16325523
[TBL] [Abstract][Full Text] [Related]
3. Effects of antiglaucoma drugs GLC756, a novel dopamine D2 agonist and D1 antagonist, and timolol on endotoxin-induced TNF-alpha release in serum of rats.
Laengle UW; Markstein R; Schneider V; Roman D
Eur J Ophthalmol; 2006; 16(3):401-6. PubMed ID: 16761241
[TBL] [Abstract][Full Text] [Related]
4. Effects of antiglaucoma drugs timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist, on endotoxin-induced-uveitis in rats.
Laengle UW; Markstein R; Schneider V; Greiner B; Roman D
Exp Eye Res; 2005 Jun; 80(6):847-52. PubMed ID: 15939041
[TBL] [Abstract][Full Text] [Related]
5. Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cells.
Laengle UW; Markstein R; Pralet D; Seewald W; Roman D
Exp Eye Res; 2006 Dec; 83(6):1335-9. PubMed ID: 16965772
[TBL] [Abstract][Full Text] [Related]
6. Antiglaucoma drug GLC756 and its effect on cellular cAMP and tumor necrosis factor alpha release in vitro of activated human monocytic leukemia cells.
Laengle UW; Markstein R; Cazaubon C; Roman D
Jpn J Ophthalmol; 2009 Mar; 53(2):159-163. PubMed ID: 19333701
[TBL] [Abstract][Full Text] [Related]
7. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
8. 5-HT1A receptors and the tail-flick response. V. Opposite modulation of 5-HT1A receptor-induced spontaneous tail-flicks by alpha 1A- as compared with alpha 2D-adrenoceptors in rat lumbar spinal cord.
Bervoets K; Millan MJ
J Pharmacol Exp Ther; 1994 Apr; 269(1):110-20. PubMed ID: 7909554
[TBL] [Abstract][Full Text] [Related]
9. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
10. Non-serotonergic potentiation by (-)-pindolol of DOI-induced forward locomotion in rats: possible involvement of beta-adrenoceptors?
Kaur P; Ahlenius S
J Neural Transm (Vienna); 2000; 107(8-9):903-17. PubMed ID: 11041271
[TBL] [Abstract][Full Text] [Related]
11. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
Millan MJ; Rivet JM; Gobert A; Canton H; Veiga S; Bervoets K
J Pharmacol Exp Ther; 1994 Apr; 269(1):121-31. PubMed ID: 7909555
[TBL] [Abstract][Full Text] [Related]
12. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
[TBL] [Abstract][Full Text] [Related]
13. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
[TBL] [Abstract][Full Text] [Related]
14. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
Misane I; Ogren SO
Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
[TBL] [Abstract][Full Text] [Related]
15. Involvement of dopamine autoreceptors in the hypoactivity induced by 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
Chojnacka-Wójcik E
Pol J Pharmacol Pharm; 1992; 44(2):135-46. PubMed ID: 1357637
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
17. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat.
Deckert V; Chaouloff F; Richer C; Elghozi JL
Arch Int Pharmacodyn Ther; 1990; 306():114-29. PubMed ID: 1981665
[TBL] [Abstract][Full Text] [Related]
18. In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol.
Hjorth S; Sharp T
J Pharmacol Exp Ther; 1993 May; 265(2):707-12. PubMed ID: 8098761
[TBL] [Abstract][Full Text] [Related]
19. Adrenergic β2-receptor mediates itch hypersensitivity following heterotypic chronic stress in rats.
Peng XY; Huang Y; Wang XL; Cao LF; Chen LH; Luo WF; Liu T
Neuroreport; 2015 Dec; 26(17):1003-10. PubMed ID: 26426856
[TBL] [Abstract][Full Text] [Related]
20. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
Clarke RW; Ogilvie J; Houghton AK
Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]